Drug
Cysteamine Bitartrate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Product Odour Abnormal | 13 | 25.4 | 25.7 | signal |
| 2 | Eye Irritation | 61 | 22.2 | 23.5 | signal |
| 3 | Dialysis | 15 | 21.4 | 21.7 | signal |
| 4 | Product Use Complaint | 12 | 15.7 | 15.9 | signal |
| 5 | Appendicitis | 6 | 13.1 | 13.2 | signal |
| 6 | Conjunctivitis | 11 | 12.1 | 12.3 | signal |
| 7 | Ocular Hyperaemia | 26 | 11.3 | 11.6 | signal |
| 8 | Product Administration Error | 11 | 11.2 | 11.3 | signal |
| 9 | Impaired Gastric Emptying | 7 | 11.1 | 11.2 | signal |
| 10 | Treatment Noncompliance | 29 | 10.8 | 11.1 | signal |
| 11 | Eye Pain | 29 | 10.7 | 10.9 | signal |
| 12 | Product Physical Issue | 9 | 9.2 | 9.2 | signal |
| 13 | Device Occlusion | 6 | 8.8 | 8.8 | signal |
| 14 | Complication Associated With Device | 5 | 7.7 | 7.7 | signal |
| 15 | Intestinal Perforation | 4 | 7.2 | 7.2 | signal |
| 16 | Eye Inflammation | 3 | 6.5 | 6.5 | signal |
| 17 | Hair Colour Changes | 4 | 6.5 | 6.5 | signal |
| 18 | Product Taste Abnormal | 3 | 4.5 | 4.5 | signal |